You have 9 free searches left this month | for more free features.

pet

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Parkinson Disease, Essential Tremor Trial in Clermont-Ferrand, Nîmes, Toulouse (SPECT, PET)

Recruiting
  • Parkinson Disease
  • Essential Tremor
  • Clermont-Ferrand, France
  • +2 more
Aug 19, 2022

Florbetaben PET Imaging in PPA

Completed
  • Primary Progressive Aphasia
  • Alzheimer Disease
  • Florbetaben F18
  • PET
  • Chicago, Illinois
    Cognitive Neurology and Alzheimer's Disease Center - Northwester
Feb 21, 2022

Tumor, Esophageal, Squamous Cell Carcinoma Trial in Guanzhou (drug, radiation, device)

Recruiting
  • Neoplasm, Esophageal
  • Squamous Cell Carcinoma
  • Guanzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 21, 2021

Lymphoma Trial in Stanford, Reading (drug, diagnostic test, radiation)

Terminated
  • Lymphoma
  • Stanford, California
  • +1 more
Dec 1, 2020

Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharyngeal Tumors Trial in Germany (drug, radiation, procedure, behavioral)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Aachen, Germany
  • +28 more
Aug 24, 2023

Obesity Trial run by the NIDDK (other, drug, device)

Completed
  • Obesity
  • Reduced fat diet
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 24, 2021

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (FMISO, MRI, PET)

Completed
  • Adult Giant Cell Glioblastoma
  • +2 more
  • Birmingham, Alabama
  • +13 more
Mar 14, 2019

Baseline, Blocking Receptor Binding Trial run by the NIMH (Emapunil, PET)

Completed
  • Baseline
  • Blocking Receptor Binding
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 26, 2018

Alzheimer's Disease (AD) Trial in Marseille (Neuraceq (florbetaben 18F), PET)

Completed
  • Alzheimer's Disease (AD)
  • Neuraceq (florbetaben 18F)
  • PET
  • Marseille, France
    Coordinating center (Hôpital de La Timone) and 18 associated cen
Mar 15, 2018

Depressive Disorder and Anxiety Disorders Trial in London (GSK424887, Placebo, PET)

Completed
  • Depressive Disorder and Anxiety Disorders
  • London, United Kingdom
    GSK Investigational Site
Aug 10, 2017

Depressive Disorder and Anxiety Disorders Trial in London (GSK206136, PLACEBO, PET)

Completed
  • Depressive Disorder and Anxiety Disorders
  • London, United Kingdom
    GSK Investigational Site
Aug 9, 2017

Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in United States (CT, 18F-FLT, PET)

Completed
  • Stage IIB Breast Cancer
  • +3 more
  • CT
  • +2 more
  • Scottsdale, Arizona
  • +26 more
Dec 28, 2016

Breast Cancer Trial in Saint Louis (radiation, other, drug)

Completed
  • Breast Cancer
  • PET
  • +3 more
  • Saint Louis, Missouri
    Washington University / Barnes-Jewish Hospital
Dec 7, 2015

Breast Cancer Trial in Taipei (PET)

Unknown status
  • Breast Cancer
  • PET
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 13, 2013